Home  >  Products  >  NCOA4 (nuclear receptor coactivator 4 ) Blocking Peptide (the C terminal of NCOA4)(100ug)
NCOA4 (nuclear receptor coactivator 4 ) Blocking Peptide (the C terminal of NCOA4)(100ug)

NCOA4 (nuclear receptor coactivator 4 ) Blocking Peptide (the C terminal of NCOA4)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NCOA4 Antibody (ARP35774_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP35774
Size: 100ug
Weight: 70kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes an androgen receptor coactivator. The encoded protein interacts with the androgen receptor in a ligand-dependent manner to enhance its transcriptional activity. Chromosomal translocations between this gene and the ret tyrosine kinase gene, also located on chromosome 10, have been associated with papillary thyroid carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes are present on chromosomes 4, 5, 10, and 14.
Alternative names: ARA70; DKFZp762E1112; ELE1; PTC3; RFG
See Full Product Listings >